Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Tzu-Hsien Lai, Wen-Fu Wang, Bak-Sau Yip, Yu-Wan Yang, Giia-Sheun Peng, Shih-Jei Tsai, Yi-Chu Liao & Ming-Chyi Pai. (2016) Real-world evaluation of compliance and preference in Alzheimer’s disease treatment: an observational study in Taiwan. Patient Preference and Adherence 10, pages 383-390.
Read now
Read now
Daniela Galimberti & Elio Scarpini. (2016) Old and new acetylcholinesterase inhibitors for Alzheimer’s disease. Expert Opinion on Investigational Drugs 25:10, pages 1181-1187.
Read now
Read now
Ming-Chyi Pai, Hany Aref, Nazem Bassil, Nagaendran Kandiah, Jae-Hong Lee, AV Srinivasan, Shelley diTommaso & Ozgur Yuksel. (2015) Real-world evaluation of compliance and preference in Alzheimer’s disease treatment. Clinical Interventions in Aging 10, pages 1779-1788.
Read now
Read now
Secundino López-Pousa & Francisco Javier Arranz. (2013) Characteristics of patients with Alzheimer’s disease who switch to rivastigmine transdermal patches in routine clinical practice. Patient Preference and Adherence 7, pages 47-54.
Read now
Read now
Kyung Hee Kim & Hye Sun Gwak. (2011) Effects of vehicles on the percutaneous absorption of donepezil hydrochloride across the excised hairless mouse skin. Drug Development and Industrial Pharmacy 37:9, pages 1125-1130.
Read now
Read now
Jonathan M. Silver, Barbara Koumaras, Xiangyi Meng, Steven G. Potkin, Patricio F. Reyes, Philip D. Harvey, Douglas I. Katz, Ibrahim Gunay & David B. Arciniegas. (2009) Long-term effects of rivastigmine capsules in patients with traumatic brain injury. Brain Injury 23:2, pages 123-132.
Read now
Read now
Andreas Wentrup, Wolfgang H Oertel & Richard Dodel. (2008) Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease. Drug Design, Development and Therapy 2, pages 245-254.
Read now
Read now
Bengt Winblad & João Carlos Machado. (2008) Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease. Expert Opinion on Drug Delivery 5:12, pages 1377-1386.
Read now
Read now
Stefania Lalli & Alberto Albanese. (2008) Rivastigmine in Parkinson’s disease dementia. Expert Review of Neurotherapeutics 8:8, pages 1181-1188.
Read now
Read now
Articles from other publishers (22)
Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez & Lucía Melguizo-Rodríguez. (2022) Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 14:6, pages 1117.
Crossref
Crossref
Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed F. Alajmi, Afzal Hussain, Md. Imtaiyaz Hassan, Faizan Ahmad & Asimul Islam. (2020) Probing the interaction of Rivastigmine Tartrate, an important Alzheimer's drug, with serum albumin: Attempting treatment of Alzheimer's disease. International Journal of Biological Macromolecules 148, pages 533-542.
Crossref
Crossref
Norifumi Tsuno, Takahiro Mori, Ichiro Ishikawa, Nobuyasu Bando, Haeyoung Park, Yoshito Matsumoto, Itsuko Mori, Mariko Tanaka, Takayuki Hirano & Yu Nakamura. (2019) Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study. Geriatrics & Gerontology International 19:7, pages 571-576.
Crossref
Crossref
Janis M. Miyasaki. 2019. Neuropalliative Care. Neuropalliative Care
59
72
.
Rosaliana Libro, Sabrina Giacoppo, Thangavelu Soundara Rajan, Placido Bramanti & Emanuela Mazzon. (2016) Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview. Molecules 21:4, pages 518.
Crossref
Crossref
Jacqueline S Birks, Lee-Yee Chong & John Grimley Evans. (2015) Rivastigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jacqueline S Birks & John Grimley Evans. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
R. Reñé, J. Ricart & B. Hernández. (2014) From high doses of oral rivastigmine to transdermal rivastigmine patches: user experience and satisfaction among caregivers of patients with mild to moderate Alzheimer disease. Neurología (English Edition) 29:2, pages 86-93.
Crossref
Crossref
R. Reñé, J. Ricart & B. Hernández. (2014) Experiencia de uso y satisfacción con rivastigmina transdérmica en cuidadores de pacientes con enfermedad de Alzheimer de leve a moderada previamente tratados con rivastigmina oral a dosis altas. Neurología 29:2, pages 86-93.
Crossref
Crossref
Lawrence S. Honig & Clara D. Boyd. (2013) Treatment of Alzheimer’s Disease: Current Management and Experimental Therapeutics. Current Translational Geriatrics and Experimental Gerontology Reports 2:3, pages 174-181.
Crossref
Crossref
Kongkiat KULKANTRAKORN, Panas TANYAKITPISAL, Somchai TOWANABUT, Charungthai DEJTHEVAPORN, Poonsri RANGSEEKAJEE, Sunsanee PONGPAKDEE, Somsak LAPTIKULTHAM, Kritsada RODPRASERT, Suwanna SETTHAWATCHARAWANICH & Bandit THINKHAMROP. (2012) Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand. Psychogeriatrics 13:1, pages 1-8.
Crossref
Crossref
S. del Rio-Sancho, C.E. Serna-Jiménez, M.A. Calatayud-Pascual, C. Balaguer-Fernández, A. Femenía-Font, V. Merino & A. López-Castellano. (2012) Transdermal absorption of memantine – Effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity. European Journal of Pharmaceutics and Biopharmaceutics 82:1, pages 164-170.
Crossref
Crossref
Li Xie, Sarah L. Kinnings, Lei Xie & Philip E. Bourne. 2012. Drug Repositioning. Drug Repositioning
163
205
.
Gustavo Alva, George T. Grossberg, Frederick A. Schmitt, Xiangyi Meng & Jason T. Olin. (2011) Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses. International Journal of Geriatric Psychiatry 26:4, pages 356-363.
Crossref
Crossref
Rüdiger Hardeland. (2011) Cognitive Enhancers in Moderate to Severe Alzheimer's Disease. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6344.
Crossref
Crossref
Martin Steinberg & Constantine G. Lyketsos. 2010. Principles and Practice of Geriatric Psychiatry. Principles and Practice of Geriatric Psychiatry
304
311
.
Ejaz Nazir & Muhammad Mushtaq. (2010) A prospective study on the use of rivastigmine transdermal patch in Alzheimer's dementia in a routine clinical setting. Dementia & Neuropsychologia 4:3, pages 245-249.
Crossref
Crossref
Murat Emre, Roberto Bernabei, Rafael Blesa, Roger Bullock, Luis Cunha, Hugo Daniëls, Edward Dziadulewicz, Hans Förstl, Lutz Frölich, Tomasz Gabryelewicz, Oleg Levin, James Lindesay, Pablo Martínez‐Lage, Andreas Monsch, Magda Tsolaki & Teus Van Laar. (2010) Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease. CNS Neuroscience & Therapeutics 16:4, pages 246-253.
Crossref
Crossref
Aurelia Santoro, Paola Siviero, Nadia Minicuci, Elena Bellavista, Michele Mishto, Fabiola Olivieri, Francesca Marchegiani, Andrea Maria Chiamenti, Luisa Benussi, Roberta Ghidoni, Benedetta Nacmias, Silvia Bagnoli, Andrea Ginestroni, Osvaldo Scarpino, Emidio Feraco, Walter Gianni, Guido Cruciani, Roberto Paganelli, Angelo Di Iorio, Mario Scognamiglio, Luigi Maria Edoardo Grimaldi, Carlo Gabelli, Sandro Sorbi, Giuliano Binetti, Gaetano Crepaldi & Claudio Franceschi. (2010) Effects of Donepezil, Galantamine and Rivastigmine in 938 Italian Patients with Alzheimerʼs Disease. CNS Drugs 24:2, pages 163-176.
Crossref
Crossref
C. Sadowsky, J.A. Davila Perez, R.W. Bouchard, I. Goodman & S. Tekin. (2010) Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch. CNS Neuroscience & Therapeutics 16:1, pages 51-60.
Crossref
Crossref
Puneet Kumar & Anil Kumar. (2009) Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: Possible behavioural, biochemical and cellular alterations. European Journal of Pharmacology 615:1-3, pages 91-101.
Crossref
Crossref
Jacqueline Birks, John Grimley Evans, Vasso Iakovidou & Magda Tsolaki. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.